TMC-169, a new antibiotic of the aspochalasin group produced by Aspergillus flavipes.
Kohno
J
J
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Saitama, Japan.
Nonaka
N
N
Nishio
M
M
Ohnuki
T
T
Kawano
K
K
Okuda
T
T
Komatsubara
S
S
D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D001230:Aspergillus / Q000378:metabolism*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D016923:Cell Death / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002850:Chromatography, Gel; D002851:Chromatography, High Pressure Liquid; D005285:Fermentation; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D013053:Spectrophotometry; D014407:Tumor Cells, Cultured
D000900:Anti-Bacterial Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; C121125:TMC 169